SCHEMBL1276175

SCHEMBL1276175

CCC(N)C=C(C)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 1/20 0.34
SLC1A2 P43004 1/20 0.34
SLC1A1 P43005 1/20 0.34
GRIK1 P39086 8/20 0.34
GRIK2 Q13002 4/20 0.34
GRIA4 P48058 3/20 0.34
GRIK3 Q13003 3/20 0.34
GRIK5 Q16478 3/20 0.34
GRIA2 P42262 2/20 0.34
GRIA1 P42261 1/20 0.34
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2A Q12879 1/20 0.33
GRIN2B Q13224 1/20 0.33
GRIN2C Q14957 1/20 0.33
GRIN3A Q8TCU5 1/20 0.33
PTGS1 P23219 1/20 0.30
AKR1C3 P42330 1/20 0.30
SLC6A2 P23975 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10322258 0.98 GRIK1 (0.33) SLC1A3SLC1A2SLC1A1GRIK1GRIK2
SCHEMBL7644311 0.83 GRIK1 (0.38) SLC1A3SLC1A2SLC1A1GRIK1GRIK2
SCHEMBL17309690 0.82 GRIK1 (0.34) GRIK1GRIK2GRIA4GRIK3GRIK5
SCHEMBL116655 0.82 KDM4E (0.33) SLC1A3SLC1A2SLC1A1BLM
SCHEMBL819568 0.82 KDM4E (0.33) SLC1A3SLC1A2SLC1A1BLM
SCHEMBL29154545 0.80 GRIK1 (0.33) GRIK1GRIK2GRIA4GRIK3GRIK5
Hydrochloric Acid SCHEMBL3491596 0.80 KDM4E (0.32)
Hydrochloric Acid SCHEMBL321069 0.80 KDM4E (0.32)
SCHEMBL3292256 0.77 ALDH1A1 (0.33)
SCHEMBL6361522 0.77 KDM4E (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 147 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025018283-A1 MEDICAL INSTRUMENT AND MANUFACTURING METHOD THEREFOR テルモ株式会社 2025-01-23 WO claimed
US-20230100363-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF ORCA HOLDINGS, LLC 2023-03-30 US claimed
US-20220177666-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF ORCA HOLDINGS, LLC 2022-06-09 US claimed
CN-114585686-A Polybutylene terephthalate composition and plastic/metal hybrid composite material 巴斯夫欧洲公司 2022-06-03 CN claimed
EP-3938359-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF 6th Wave Innovations Corp. (US) 2022-01-19 EP claimed
WO-2020186077-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF 6th Wave Innovations Corp. (US) 2020-09-17 WO claimed
CN-103881128-A Preparation method of in-situ glucose detecting membrane based on fluorescence detection method HUANG PENG 2014-06-25 CN claimed
WO-2011037349-A2 TARGET SPECIFIC DRUG DELIVERY SYSTEM, TARGET NON-SPECIFIC LONG-ACTING DRUG DELIVERY SYSTEM AND METHOD OF CONTROLLING TARGET SPECIFICITY THEREOF POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) 2011-03-31 WO claimed
EP-2285746-A1 WATER SOFTENER COMPOSITION Dalli-Werke GmbH & Co. KG (DE) 2011-02-23 EP claimed
CN-101351490-A Chitosan or hyaluronic acid-poly (ethylene oxide) -and chitosan-hyaluronic acid-poly (ethylene oxide) -based hydrogels and methods of making the same SEOUL NATIONL UNIVERSITY OF TE (KR) 2009-01-21 CN claimed
WO-2008074402-A1 WATER SOFTENER COMPOSITION DALLI-WERKE GMBH & CO. KG (DE) 2008-06-26 WO claimed
US-5837773-A ETHYLENE-PROPYLENE COPOLYMER DSM COPOLYMER, INC. (US) 1998-11-17 US claimed
US-5451636-A Ethylene-proylene copolymer or graft polymer DSM COPOLYMER, INC. (US) 1995-09-19 US claimed
US-5391617-A High and low ethylene content ethylene-propylene copolymer includes copolyenes, acrylic and vinyl amines DSM COPOLYMER, INC. (US) 1995-02-21 US claimed
WO-2025018283-A1 MEDICAL INSTRUMENT AND MANUFACTURING METHOD THEREFOR テルモ株式会社 2025-01-23 WO disclosed
EP-3545055-B1 PARTICULATE MATERIAL AND METHOD FOR REMOVING ONE OR MORE CONTAMINANTS FROM HYDROCARBON GAS COMMW SCIENT IND RES ORG (AU) 2024-11-13 EP disclosed
US-20230100363-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF ORCA HOLDINGS, LLC 2023-03-30 US disclosed
US-5391617-A High and low ethylene content ethylene-propylene copolymer includes copolyenes, acrylic and vinyl amines DSM COPOLYMER, INC. (US) 1995-02-21 US disclosed
EP-0637611-A2 Solid sheared polymer blends DSM Copolymer, Inc. (US) 1995-02-08 EP disclosed
US-4256621-A A CONJUGATED DIENE POLYMER MODIFIED BY MALEIC ANHYDRIDE, AN AMINE-CONTAINING ALCOHOL, AN EPOXY COMPOUND, A PRIMARY OR SECONDARY AMINE, AND A PARTIALLY BLOCKED ISOCYANATE; PRIMERS FOR CARS NIPPON SODA COMPANY, LTD. (JP) 1981-03-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230100363-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF CNR2, CNR1, CDIPT SLC1A3 2698/4885SLC1A2 2407/4885SLC1A1 2500/4885
US-20220177666-A1 MOLECULARLY IMPRINTED POLYMERS FOR EXTRACTION OF CANNABINOIDS AND USES THEREOF CNR2, CNR1, CDIPT SLC1A3 2698/4885SLC1A2 2407/4885SLC1A1 2500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.